1. 77.9k

    Australian Pharmaceutical Industries (ASX:API) today confirmed that a class action has
    been filed against it in Victoria’s Supreme Court. API denies the plaintiffs’ allegations and
    will vigorously defend the action.
    API said that it remains focused on supporting Priceline Pharmacy franchisees through
    these difficult COVID-19 times, so that they can fully play their role in the distribution of vital
    medicines and the COVID-19 vaccine and serve their communities during and beyond the
    Given the matters alleged by the plaintiffs are now before a Court, it would be
    inappropriate for API to comment further.
    Announcement authorised by the CEO & Managing Director of API.


    i hold API

Your browser is too old for TopStocks and not secure. Please update your browser